Cyprus Business Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Business Journal.

Press releases published on October 1, 2026

Sompo appoints Scott Toland as Head of Commercial Lines, Insurance, Continental Europe
FAU’s MBA in Sport Management Ranks No. 7 Globally
Townsquare and Lakes Media Network Announce Digital  Advertising Partnership Serving Virginia and North Carolina
Global Liver Institute’s 2026 #OctoberIs4Livers Campaign Calls for Action Across the Liver Cancer Journey
Acuity Reports Fiscal 2026 Fourth-Quarter and Full-Year Results
Origence Expands Lending Network with New Auto Refinance Solution for Credit Unions
Enerflex Ltd. Announces Contract Award for Large-Scale Data Center Development
CHUCK E. CHEESE ANNOUNCES BOO-TACULAR: LARGEST KID-FOCUSED HALLOWEEN CELEBRATION
American Battery Technology Company Receives Approval for Sale of $100 Million of Exported Recycled Black Mass Critical Minerals with License from U.S. Department of Commerce
Rakovina Therapeutics Partners with Boston-based Celvion Therapeutics to Leverage AI and Real-World Clinical Data for Precision Cancer Drug Development
Dantax A/S - Ledende medarbejders transaktioner
New Travel Industry Coalition Calls for EU Digital Omnibus to Enable Secure, Seamless Biometric Journeys
Allogenetics Appoints Dr. Olaf Schermeier as Chairman of the Advisory Board
Startup Accelerated by Unicorn Factory Lisboa Wins International AI Award in Taiwan
Startup acelerada pela Unicorn Factory Lisboa vence prémio internacional de IA em Taiwan
Hyster hydrogen fuel cell ReachStacker supports sustainable ports project at Rotterdam Short Sea Terminals
FTI Consulting Expands UK Turnaround & Restructuring Capabilities With Four Senior Hires
Huntress Accelerates European Expansion Through New ALSO Partnership
Numab Therapeutics Appoints Dr. Rajesh Chopra as Chief Scientific Officer to Advance its Proprietary Multispecific Antibody Pipeline
Zealand Pharma announces Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new Phase III trial, alongside significant improvements in glycemic control in people with obesity and type 2 diabetes

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Cyprus Business Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.